Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MCRBthis companySeres Therapeutics, Inc.	$1.71	23.25×	2.98×	167.07×	17.2×	-268.8%	-423.8%	-11910.1%	721.9%	12.9%	-72.7%	0.7%	1.88×	3.78×	0×	2.56×	0.0%	2	-24.16	1	C-
ABOSAcumen Pharmaceuticals, Inc.	$0.25	-1.06×	1.81×	0×	-0.9×	51.5%	0.0%	0.0%	0.0%	-172.3%	-121.7%	-90.5%	0.44×	0.19×	-29.32×	4.07×	0.0%	2	-11.67	2	C
ACTUActuate Therapeutics Inc	$0.33	-5.77×	16.24×	0×	-5.22×	63.5%	0.0%	0.0%	0.0%	-280.5%	-270.1%	-14.9%	0.05×	0.57×	-1,110.88×	2.39×	0.0%	2	-56.07	2	C
CGTXCognition Therapeutics, Inc.	$0.70	-4.22×	2.87×	0×	-2.67×	-14.8%	0.0%	0.0%	0.0%	-68.5%	-136.9%	-25.0%	0.02×	1.56×	-3,676.85×	3.45×	0.0%	2	-1.92	2	C+
HURATuHURA Biosciences, Inc.	$1.70	-1.2×	1.73×	0×	-1.14×	-100.8%	0.0%	0.0%	0.0%	-143.6%	-145.7%	-76.4%	0.03×	0.1×	-50.85×	0.78×	0.0%	1	-5.35	2	C
INOInovio Pharmaceuticals, Inc.	$1.49	-0.96×	3.39×	1,248.52×	-0.57×	-54.3%	100.0%	-132871.3%	-130000.0%	-352.5%	-259.4%	-109.0%	0.39×	0.43×	0×	1.4×	0.0%	0	-55.57	1	C-
Peer median	—	-1.2×	2.87×	0×	-1.14×	-14.8%	0.0%	0.0%	0.0%	-172.3%	-145.7%	-76.4%	0.05×	0.43×	-50.85×	2.39×	0.0%	2	-11.67	2	—